Autologous Biologics Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Autologous Biologics Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
The Global Autologous Biologics Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like {playerNamesStr}
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Autologous Biologics study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Autologous Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Autologous Biologics Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Autologous Biologics companies in 2021 (%)
The global Autologous Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adipose Tissue Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Autologous Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Autologous Biologics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Autologous Biologics Market Segment Percentages, by Type, 2021 (%)
Adipose Tissue
Plasma
Others
Global Autologous Biologics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Autologous Biologics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Centers
Research Centers
Global Autologous Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Autologous Biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autologous Biologics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Autologous Biologics revenues share in global market, 2021 (%)
Key companies Autologous Biologics sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Autologous Biologics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Vericel Corporation
BioTime, Inc.
Pharmicell Co.
BrainStorm Cell Therapeutics
Opexa Therapeutics, Inc
Pharmicell Co., Inc
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Autologous Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Biologics Overall Market Size
2.1 Global Autologous Biologics Market Size: 2021 VS 2028
2.2 Global Autologous Biologics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Autologous Biologics Sales: 2017-2028
3 Company Landscape
3.1 Top Autologous Biologics Players in Global Market
3.2 Top Global Autologous Biologics Companies Ranked by Revenue
3.3 Global Autologous Biologics Revenue by Companies
3.4 Global Autologous Biologics Sales by Companies
3.5 Global Autologous Biologics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Autologous Biologics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Autologous Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autologous Biologics Players in Global Market
3.8.1 List of Global Tier 1 Autologous Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Autologous Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Autologous Biologics Market Size Markets, 2021 & 2028
4.1.2 Adipose Tissue
4.1.3 Plasma
4.1.4 Others
4.2 By Type - Global Autologous Biologics Revenue & Forecasts
4.2.1 By Type - Global Autologous Biologics Revenue, 2017-2022
4.2.2 By Type - Global Autologous Biologics Revenue, 2023-2028
4.2.3 By Type - Global Autologous Biologics Revenue Market Share, 2017-2028
4.3 By Type - Global Autologous Biologics Sales & Forecasts
4.3.1 By Type - Global Autologous Biologics Sales, 2017-2022
4.3.2 By Type - Global Autologous Biologics Sales, 2023-2028
4.3.3 By Type - Global Autologous Biologics Sales Market Share, 2017-2028
4.4 By Type - Global Autologous Biologics Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Autologous Biologics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Centers
5.1.4 Research Centers
5.2 By Application - Global Autologous Biologics Revenue & Forecasts
5.2.1 By Application - Global Autologous Biologics Revenue, 2017-2022
5.2.2 By Application - Global Autologous Biologics Revenue, 2023-2028
5.2.3 By Application - Global Autologous Biologics Revenue Market Share, 2017-2028
5.3 By Application - Global Autologous Biologics Sales & Forecasts
5.3.1 By Application - Global Autologous Biologics Sales, 2017-2022
5.3.2 By Application - Global Autologous Biologics Sales, 2023-2028
5.3.3 By Application - Global Autologous Biologics Sales Market Share, 2017-2028
5.4 By Application - Global Autologous Biologics Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Autologous Biologics Market Size, 2021 & 2028
6.2 By Region - Global Autologous Biologics Revenue & Forecasts
6.2.1 By Region - Global Autologous Biologics Revenue, 2017-2022
6.2.2 By Region - Global Autologous Biologics Revenue, 2023-2028
6.2.3 By Region - Global Autologous Biologics Revenue Market Share, 2017-2028
6.3 By Region - Global Autologous Biologics Sales & Forecasts
6.3.1 By Region - Global Autologous Biologics Sales, 2017-2022
6.3.2 By Region - Global Autologous Biologics Sales, 2023-2028
6.3.3 By Region - Global Autologous Biologics Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Autologous Biologics Revenue, 2017-2028
6.4.2 By Country - North America Autologous Biologics Sales, 2017-2028
6.4.3 US Autologous Biologics Market Size, 2017-2028
6.4.4 Canada Autologous Biologics Market Size, 2017-2028
6.4.5 Mexico Autologous Biologics Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Autologous Biologics Revenue, 2017-2028
6.5.2 By Country - Europe Autologous Biologics Sales, 2017-2028
6.5.3 Germany Autologous Biologics Market Size, 2017-2028
6.5.4 France Autologous Biologics Market Size, 2017-2028
6.5.5 U.K. Autologous Biologics Market Size, 2017-2028
6.5.6 Italy Autologous Biologics Market Size, 2017-2028
6.5.7 Russia Autologous Biologics Market Size, 2017-2028
6.5.8 Nordic Countries Autologous Biologics Market Size, 2017-2028
6.5.9 Benelux Autologous Biologics Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Autologous Biologics Revenue, 2017-2028
6.6.2 By Region - Asia Autologous Biologics Sales, 2017-2028
6.6.3 China Autologous Biologics Market Size, 2017-2028
6.6.4 Japan Autologous Biologics Market Size, 2017-2028
6.6.5 South Korea Autologous Biologics Market Size, 2017-2028
6.6.6 Southeast Asia Autologous Biologics Market Size, 2017-2028
6.6.7 India Autologous Biologics Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Autologous Biologics Revenue, 2017-2028
6.7.2 By Country - South America Autologous Biologics Sales, 2017-2028
6.7.3 Brazil Autologous Biologics Market Size, 2017-2028
6.7.4 Argentina Autologous Biologics Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Autologous Biologics Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Autologous Biologics Sales, 2017-2028
6.8.3 Turkey Autologous Biologics Market Size, 2017-2028
6.8.4 Israel Autologous Biologics Market Size, 2017-2028
6.8.5 Saudi Arabia Autologous Biologics Market Size, 2017-2028
6.8.6 UAE Autologous Biologics Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Vericel Corporation
7.1.1 Vericel Corporation Corporate Summary
7.1.2 Vericel Corporation Business Overview
7.1.3 Vericel Corporation Autologous Biologics Major Product Offerings
7.1.4 Vericel Corporation Autologous Biologics Sales and Revenue in Global (2017-2022)
7.1.5 Vericel Corporation Key News
7.2 BioTime, Inc.
7.2.1 BioTime, Inc. Corporate Summary
7.2.2 BioTime, Inc. Business Overview
7.2.3 BioTime, Inc. Autologous Biologics Major Product Offerings
7.2.4 BioTime, Inc. Autologous Biologics Sales and Revenue in Global (2017-2022)
7.2.5 BioTime, Inc. Key News
7.3 Pharmicell Co.
7.3.1 Pharmicell Co. Corporate Summary
7.3.2 Pharmicell Co. Business Overview
7.3.3 Pharmicell Co. Autologous Biologics Major Product Offerings
7.3.4 Pharmicell Co. Autologous Biologics Sales and Revenue in Global (2017-2022)
7.3.5 Pharmicell Co. Key News
7.4 BrainStorm Cell Therapeutics
7.4.1 BrainStorm Cell Therapeutics Corporate Summary
7.4.2 BrainStorm Cell Therapeutics Business Overview
7.4.3 BrainStorm Cell Therapeutics Autologous Biologics Major Product Offerings
7.4.4 BrainStorm Cell Therapeutics Autologous Biologics Sales and Revenue in Global (2017-2022)
7.4.5 BrainStorm Cell Therapeutics Key News
7.5 Opexa Therapeutics, Inc
7.5.1 Opexa Therapeutics, Inc Corporate Summary
7.5.2 Opexa Therapeutics, Inc Business Overview
7.5.3 Opexa Therapeutics, Inc Autologous Biologics Major Product Offerings
7.5.4 Opexa Therapeutics, Inc Autologous Biologics Sales and Revenue in Global (2017-2022)
7.5.5 Opexa Therapeutics, Inc Key News
7.6 Pharmicell Co., Inc
7.6.1 Pharmicell Co., Inc Corporate Summary
7.6.2 Pharmicell Co., Inc Business Overview
7.6.3 Pharmicell Co., Inc Autologous Biologics Major Product Offerings
7.6.4 Pharmicell Co., Inc Autologous Biologics Sales and Revenue in Global (2017-2022)
7.6.5 Pharmicell Co., Inc Key News
7.7 Neostem
7.7.1 Neostem Corporate Summary
7.7.2 Neostem Business Overview
7.7.3 Neostem Autologous Biologics Major Product Offerings
7.7.4 Neostem Autologous Biologics Sales and Revenue in Global (2017-2022)
7.7.5 Neostem Key News
7.8 Dendreon Corporation
7.8.1 Dendreon Corporation Corporate Summary
7.8.2 Dendreon Corporation Business Overview
7.8.3 Dendreon Corporation Autologous Biologics Major Product Offerings
7.8.4 Dendreon Corporation Autologous Biologics Sales and Revenue in Global (2017-2022)
7.8.5 Dendreon Corporation Key News
7.9 Regenexx
7.9.1 Regenexx Corporate Summary
7.9.2 Regenexx Business Overview
7.9.3 Regenexx Autologous Biologics Major Product Offerings
7.9.4 Regenexx Autologous Biologics Sales and Revenue in Global (2017-2022)
7.9.5 Regenexx Key News
7.10 Cytori Therapeutics
7.10.1 Cytori Therapeutics Corporate Summary
7.10.2 Cytori Therapeutics Business Overview
7.10.3 Cytori Therapeutics Autologous Biologics Major Product Offerings
7.10.4 Cytori Therapeutics Autologous Biologics Sales and Revenue in Global (2017-2022)
7.10.5 Cytori Therapeutics Key News
8 Global Autologous Biologics Production Capacity, Analysis
8.1 Global Autologous Biologics Production Capacity, 2017-2028
8.2 Autologous Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Autologous Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Autologous Biologics Supply Chain Analysis
10.1 Autologous Biologics Industry Value Chain
10.2 Autologous Biologics Upstream Market
10.3 Autologous Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Autologous Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Autologous Biologics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|